NCT02192970View on ClinicalTrials.gov

Bevacizumab Against Recurrent Retinal Detachment

PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

January 21, 2015

Primary Completion Date

November 11, 2019

Study Completion Date

November 11, 2019

Conditions
Retinal DetachmentProliferative Vitreoretinopathy
Interventions
DRUG

Bevacizumab

Trial Locations (1)

53705

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT02192970 - Bevacizumab Against Recurrent Retinal Detachment | Biotech Hunter | Biotech Hunter